Intravaginally administered lactic acid bacteria expedited uterine involution and modulated hormonal profiles of transition dairy cows.

The objective of this investigation was to evaluate whether intravaginal infusion of lactic acid bacteria (LAB) around parturition could expedite involution rate of the uterus and improve reproductive performance of postpartum dairy cows. One hundred pregnant Holstein dairy cows were assigned to 1 of 3 experimental groups: (1) 1 dose of LAB in wk -2 and -1 and 1 dose of carrier in wk 1 relative to the expected day of parturition (TRT1); (2) 1 dose of LAB in wk -2, -1, and 1 (TRT2); and (3) 1 dose of carrier in wk -2, -1, and 1 (CTR). The LAB treatment was a lyophilized mixture of Lactobacillus sakei FUA3089, Pediococcus acidilactici FUA3138, and Pediococcus acidilactici FUA3140 with a cell count of 10(8) to 10(9) cfu/dose. Uterine involution and ovarian activity was evaluated by transrectal ultrasonography weekly from d 7 to 49 postpartum. Blood samples were collected from a subset of cows to quantify prostaglandin (PG) F2α metabolite (PGFM), PGE2, and progesterone. Cows treated with LAB had smaller cross-sectional areas of gravid horn and uterine body on d 14 postpartum. Cows in TRT2 resumed ovarian cyclicity earlier, as indicated by increased concentrations of serum progesterone. Cows in TRT1 had fewer days open than those in the CTR (110 vs. 150 d), whereas cows in TRT2 and CTR did not differ in days open. In addition, both TRT1 and TRT2 increased the concentrations of PGFM at calving week, and cows in TRT2 also had greater concentrations of PGE2 on d 14 and d 21 postpartum relative to CTR. Overall, cows treated intravaginally with LAB had smaller gravid horn and uterine body on d 14 postpartum than those in the CTR group. Treatment with LAB also increased concentrations of serum PGFM (3,533±328pg/mL in TRT1, 4,470±372pg/mL in TRT2, and 2,000±328pg/mL in CTR on d 0, respectively), with the TRT1 group having fewer cows that resumed ovarian cyclicity but fewer days open compared with both TRT2 and CTR groups. More research is warranted to better understand the mechanism(s) by which intravaginal LAB expedited uterine involution and affected hormonal profiles.

Barley grain-based diet treated with lactic acid and heat modulated plasma metabolites and acute phase response in dairy cows.

This study investigated the effects of feeding barley grain treated with lactic acid (LA) and heat on the profile of plasma metabolites related to carbohydrate and lipid metabolism and variables related to rumen health and acute phase response. Eight primiparous rumen-fistulated lactating Holstein cows were randomly assigned, in a crossover design, to 1 of the 2 dietary treatments consisting of 32% (DM basis) rolled barley grain steeped in an equal quantity of either tap water alone (CTR) or a 1.0% LA solution and heated at 55°C for 48 h (LAH). Each experimental period was 21 d, with the last 10 d used for measurements. Blood samples were collected on d 1, 3, 5, 7, 9, and 11 before the morning feeding and on the last day of each period at 0, 2, 4, 6, 8, 10, and 12 h postfeeding to measure glucose, lactate, cholesterol, beta-hydroxybutyrate (BHBA), NEFA, haptoglobin (Hp), serum amyloid A (SAA), and tumor necrosis factor-alpha (TNF-α). Also, rumen samples were collected on d 1, 5, and 11 as well as at 0, 4, 8, and 12 h postfeeding on the last day of each period for measuring the concentration of rumen endotoxin. Results of the day-to-day analysis indicated that cows fed the LAH diet had reduced preprandial concentrations of rumen endotoxin (472 vs. 793 ng/mL; P < 0.01) and cholesterol and greater lactate in the plasma; however, treatment had no effect on plasma Hp and TNF-α (P > 0.10). Postprandial responses showed that the LAH diet tended to decrease the concentration of SAA (4.67 vs. 8.50 µg/mL; P = 0.06). Also, there was a treatment by time interaction for rumen endotoxin (P < 0.01), suggesting a role for both the treatment and the time of sampling on this variable. Furthermore, greater concentration of BHBA and a tendency for greater NEFA and reduced concentrations of plasma glucose were observed in cows fed the LAH diet. In conclusion, results indicated that feeding dairy cows barley grain steeped in 1.0% LA and treated with heat modulated the profile of plasma metabolites and acute phase response.

Dose response to cinnamaldehyde supplementation in growing beef heifers: ruminal and intestinal digestion.

The objective of this study was to determine if cinnamaldehyde (CIN) could be used to improve feed intake, digestion, and immune status in growing beef heifers fed high-concentrate diets. The experiment was designed as a 4 x 4 Latin square using 4 ruminally and duodenally cannulated beef heifers with 4 treatments: control (no CIN added), 400 mg/d of CIN (low), 800 mg/d of CIN (medium), and 1,600 mg/d of CIN (high), and four 21-d periods. Feed intake, rumen pH and fermentation characteristics, site and extent of digestion, microbial N synthesis, blood metabolites, and acute phase protein response were measured. The diets consisted of 15% barley silage, 80% dry-rolled barley grain, and 5% supplement (DM basis). Intakes (kg/d) of DM, OM, NDF, starch, and N were quadratically (P = 0.04) changed with increasing CIN supplementation. The amount of OM fermented in the rumen quadratically (P = 0.02) decreased with increasing CIN. Digestibilities (% of intake) of OM, NDF, and N in the rumen were not affected by supplementing with low and medium CIN, but they were reduced by 8% (P = 0.10), 31% (P = 0.05), and 17% (P = 0.05), respectively, with high CIN. Similarly, digestibilities of OM and NDF in the total tract also tended to be reduced by 7% (P = 0.10) and 20% (P = 0.10), respectively, with high CIN because supplementation of CIN had minimal effects on intestinal digestibility. Flows (g/d) of microbial N and other nutrients to the duodenum were not affected by CIN supplementation, even though the amount of ruminal fermented OM varied with level of CIN supplementation. Rumen pH, total VFA concentration, and molar proportions of individual VFA were not affected by CIN. Although concentrations of NEFA (P = 0.06) and triglyceride (P = 0.01) were quadratically changed with increasing CIN supplementation, blood concentrations of glucose and urea N, white blood cell counts, serum amyloid A, and lipopolysaccharide in plasma were not affected by CIN. Plasma haptoglobin numerically (P = 0.11) decreased with the medium dose of CIN fed compared with control. The results indicate that supplementation of a high-concentrate diet with a low dose of CIN resulted in small increases in nutrient availability in the rumen due to increased feed intake and greater ruminal digestion of OM. However, feed intake and ruminal digestion of feeds were adversely affected when a high dose of CIN was used.

Cinnamaldehyde in feedlot cattle diets: intake, growth performance, carcass characteristics, and blood metabolites.

Cinnamaldehyde (CIN), a natural chemical compound found in the bark of cinnamon trees, can alter rumen fermentation by inhibiting selected ruminal microbes, and consequently, may improve growth performance and feed efficiency of animals. The objective of this study was to evaluate the effects of supplementing the diet of feedlot cattle with CIN on intake, growth performance, carcass characteristics, and blood metabolites. Seventy yearling steers (BW = 390 +/- 25.2 kg) were assigned to a randomized complete block design with 5 treatments: control (no additive), monensin (MO; 330 mg*steer(-1)*d(-1)), and 400, 800, or 1,600 mg of CIN*steer(-1)*d(-1). At the start of the experiment, steers were blocked according to BW and assigned to 14 blocks of 5 cattle, with cattle within block assigned to treatments. The diets consisted of 9% barley silage, 86% dry-rolled barley grain, and 5% supplement (DM basis). Dry matter intake responded quadratically (P = 0.03) to CIN supplementation with 13% more feed consumed for steers fed CIN (mean of 3 CIN levels) compared with those fed control during the first 28 d of the experiment, and with a tendency of 4% increase over the entire experiment. The ADG (kg/d) tended to respond quadratically (P = 0.08) to CIN supplementation during the first 28 d, but was not affected over the entire experiment (112 d). Feed efficiency (G:F) linearly declined (P = 0.03) during the first 28 d with CIN supplementation and was quadratically affected between d 29 to 56 and d 85 to 112 by CIN dose. Supplementation of MO did not affect (P > 0.15) DMI or growth performance at any time during the experiment. Serum NEFA concentrations were reduced (P = 0.05) by 35, 29, 30, and 22%, respectively, on d 56, 84, 112, and overall with CIN supplementation. Concentrations of serum amyloid A were reduced on d 28 by 56, 60, or 56% for 800 mg of CIN, 1,600 mg of CIN, and MO, respectively, compared with control. Plasma concentrations of lipopolysaccharide binding protein were linearly decreased (P = 0.05) with increasing CIN supplementation on d 28. Results indicate that supplementing a feedlot finishing diet with a small dose of CIN ameliorated feed intake during the initial month but had minimal effects on ADG, feed efficiency, and carcass traits over the entire experiment. Including CIN in the diet of feedlot cattle, particularly early in the feeding period, may help promote intake and reduce the effects of stress.

The effect of porcine luteinizing hormone in the synchronization of ovulation and corpus luteum development in nonlactating cows.

The objective of this study was to determine the effects of different doses of porcine luteinizing hormone (pLH) versus 100 microg gonadotropin-releasing hormone (GnRH) on ovulatory response (during diestrus and proestrus) and corpus luteum (CL) development in nonlactating cows. In Experiment 1, 75 cows received an intravaginal insert containing 1.9 g progesterone (P4) for 10 d to synchronize estrus (Day 0), with prostaglandin F(2 alpha) (PGF) at insert removal. On Day 5, all follicles >or=8mm were ablated, and on Day 12, cows received 8, 12.5, or 25mg pLH or 100 microg GnRH. Mean (+/-SEM) plasma P4 concentrations on Day 12 did not differ among treatments (5.6+/-0.2 ng/mL). Mean plasma LH concentration was greatest (P<0.01) in cows given 25mg pLH (4.3+/-0.4 ng/mL). The ovulatory response to 25mg pLH (84%) or 100 microg GnRH (72%) was greater (P<0.05) than that to 8 mg pLH (32%), but not different from that of 12.5mg pLH (58%). In Experiment 2, 68 cows were given two injections of PGF 10d apart to synchronize estrus (Day 0). On Day 7, cows received PGF, and, 36 h later, pLH or GnRH (as in Experiment 1). The interval from treatment to ovulation was most variable in cows given 8 mg pLH; only 65% of these cows ovulated during the initial 27 h versus 88% of cows given 25mg pLH (P<0.05). Cows given 25mg pLH or 100 microg GnRH had larger CL area and greater plasma P4 concentrations (P<0.05) than that of those given 8 mg pLH. In summary, diestrous cows given 25mg pLH had the greatest plasma luteinizing hormone concentrations, but ovulatory response did not differ from that of those given 100 microg GnRH. Proestrous cows given 25mg pLH or 100 microg GnRH had greater CL area and P4 concentrations than that of those given 8 mg pLH.

Exogenous glucagon effects on health and reproductive performance of lactating dairy cows with mild fatty liver.

Severe fatty liver, a metabolic disease of dairy cows in early lactation, results in decreased health and reproductive performance, but can be alleviated by treatment with i.v. injections of glucagon. Mild fatty liver in cows effects on health and reproductive performance were determined by treatment with 14-day s.c. injections of glucagon at 7.5 or 15 mg/day. Multiparous Holstein cows (n=32) were grouped into Normal and Susceptible based on liver triacylglycerol concentrations (>1% liver tissue biopsy wet weight) at day 8 postpartum (day 0=day of parturition). Susceptible cows (n=24) were assigned randomly to three groups and s.c. injected with 0mg glucagon [60 ml 0.15M NaCl] [n=8] (same for Normal cows), 2.5 mg glucagon, or 5 mg glucagon every 8 h for 14 days, beginning day 8 postpartum. Mild fatty liver resulted in an increased number of days with elevated body temperature during the injection period, an increased incidence of mastitis after glucagon treatment, increased days to first estrus and insemination, increased days before conception occurred, and decreased conception rate. In cows with mild fatty liver, glucagon (15 mg/day) decreased the number of days with elevated body temperature and the incidence of mastitis after hormone treatment. From these results, we suggest that mild fatty liver is detrimental to health and reproduction of dairy cows and, furthermore, that exogenous glucagon decreases some of these detrimental effects.